Reliable prevalence  estimates are lacking for young-onset dementia (YOD), in which symptoms of  dementia start before the age of 65 years. Such estimates are needed for policymakers to organize appropriate health care.
    A study was conducted  by a group of researchers from the Netherlands to determine the global prevalence  of young-onset dementia (YOD).
    The researchers systematically  searched databases like PubMed, Embase, CINAHL, and PsycInfo for  population-based studies on the prevalence of young-onset dementia (YOD) published  between January 1, 1990, and March 31, 2020.
    Two researchers screened  studies containing data on the prevalence of dementia in individuals younger  than 65 years for inclusion in a systematic review and meta-analysis.
    The main outcome of  the study was Prevalence estimates of young-onset dementia (YOD) for 5-year age  bands.
    The results of the study  are as follows:
    - A total of  95 unique studies were included in this systematic review, of which 74 with 2  760 379 unique patients were also included in 5-year age band meta-analyses. 
- Studies  were mostly conducted in Europe and in older groups in Asia, North America, and  Oceania. 
- Age-standardized  prevalence estimates increased from 1.1 per 100 000 population in the group  aged 30 to 34 years to 77.4 per 100 000 population in the group aged 60 to 64  years. 
- This gives  an overall global age-standardized prevalence of 119.0 per 100 000 population  in the age range of 30 to 64 years, corresponding to 3.9 million people aged 30  to 64 years living with YOD in the world. 
- Subgroup  analyses showed prevalence between men and women to be similar, whereas  prevalence was lower in high-income countries compared with upper-middle-income  and lower-middle-income countries. 
- Meta-regression  showed that age range sample size and study methodology significantly  influenced heterogeneity between studies.
Thus, the researchers  concluded that an age-standardized prevalence of YOD of 119.0 per 100 000  population, although estimates of the prevalence in low-income countries and  younger age ranges remain scarce. These results should help policymakers  organize sufficient health care for this subgroup of individuals with dementia.
    Reference:
    Global Prevalence of  Young-Onset Dementia: A Systematic Review and Meta-analysis by Hendriks S et.  al published in the JAMA Neurol 
    doi:10.1001/jamaneurol.2021.2161
 
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.